Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project
- PMID: 15509456
- DOI: 10.1007/s11916-004-0064-2
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project
Abstract
Seven oral triptans, which differ on a range of attributes important for treatment selection, are now available for treating migraine. US neurologists were surveyed to assess the relative importance of treatment attributes, prespecified by clinical relevance and availability of controlled study data, for selecting among oral triptans. Using a multiattribute decision model, we combined these data on the importance of treatment attributes with information on the relative performance of the oral triptans derived from a recent meta-analysis of controlled clinical trials.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical